Company Quick10K Filing
Yew Bio-Pharm
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-09-25 Officers
8-K 2018-11-09 Accountant, Exhibits
8-K 2018-11-01 Officers
8-K 2018-09-25 Regulation FD, Exhibits
8-K 2018-09-12 Regulation FD, Exhibits
8-K 2018-05-21 Officers
8-K 2018-04-02 Earnings, Exhibits

Yew Bio-Pharm Financials

-

YEWB Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash568387544301,1101,1601002311204881306111716822368499652795212,4381,34086023773522522222156
Accounts Receivable5307231,4881,7671,02841933913809232,0152,2361,6553,8581,8843,1018,56414,46816,34912,09111,7449,8825,697606,8711709,598
Inventory9009911,3511,2471,4481,0891,5768791,7321,4432,7013,5097,7914,6669,7438,65912,57110,29710,73014,3319,3632,5793,5578,3856,7856,2056,27080
PP&E1,6131,6658348019782,0199769328941,8938297967251,7436816346871,7776736605841,8025845415261,752516490
Assets27,65628,04229,27430,89631,59935,31434,98834,11534,55735,04237,86741,91743,22843,81145,27045,56548,62446,19547,60059,19359,86052,93054,47553,35755,23549,69253,45758,513
Accounts Payable91612440042161,2174277401,65016881626811989
Long-Term Debt
Liabilities1,0332543882451754,9983,5541,2284401401,4473,1194,9444,6414,6924,7726,8687,6198,5009,0458,2797,7587,5956,20210,0418,60510,96815,837
Stockholders' Equity26,62327,78928,88630,65131,42430,31631,43432,88734,11734,90236,42038,79838,28339,17040,57840,79341,75638,57639,10050,14851,58045,17246,88047,15545,19341,08742,48942,676
Income Statement ($'000)2012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue1,3731,7992,1061,5441,9902,0682,0641,7011,8942,6424,6674,99717,2678,62016,06014,6674,7037,87515,60411,5654,5423,03114,82014,03913,45311,51412,565
Cost of Revenue2315795066386495284252948901,1712,2873,5787,2967,22714,41013,2489,6047,3555,01510,8151,0792,55211,46712,575-6,36010,35511,919
Gross Profit1,1421,2201,6019061,3051,5401,6391,4071,0041,4712,3801,4191,7631,3931,6501,419-1,22852010,590750-6,7984793,3541,4655,4271,159646
R&D
SG&A2632782783161672215144024724844854523163413001572983002618782601,287251295218
Tax000000004124-310001801810001,43211511530
Net Income8809421,3235921,0421,3751,4178935999582,0069341,3871,0501,3061,081-1,43017010,255614-7,8271491,613-381-2,7043771,436
Cash Flow ($'000)2012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating154-191,3013,0074162,437642620-356-1,216365-165-415638138281-2,6122,6194,8982,2091,7691,922
Cash Investing-234-2,961-54-3,697-7512,054-5-591-774-993-40-32430-679-7,324-1,423-1,700-4,738
Cash Financing000-0-1,4211,396-1-2,30622,29301,671-25-10-14-1,2132,860-531,953-650-3102,724